KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - NYSE:PHG - US5004723038
27.26 USD
+0.55 (+2.06%)
27.26 USD
0 (0%)
PHG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. PHG has a medium profitability rating, but doesn't score so well on its financial health evaluation. PHG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
In the past year PHG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
PHG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of PHG (0.61%) is better than 73.40% of its industry peers.
PHG has a Return On Equity of 1.56%. This is in the better half of the industry: PHG outperforms 74.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.49%, PHG is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.49% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG has a Profit Margin of 0.91%. This is in the better half of the industry: PHG outperforms 73.40% of its industry peers.
PHG has a better Operating Margin (6.11%) than 70.74% of its industry peers.
In the last couple of years the Operating Margin of PHG has declined.
With a Gross Margin value of 43.85%, PHG is not doing good in the industry: 62.23% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
Compared to 1 year ago, PHG has less shares outstanding
The number of shares outstanding for PHG has been increased compared to 5 years ago.
The debt/assets ratio for PHG is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.90 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.90, PHG is doing good in the industry, outperforming 60.11% of the companies in the same industry.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.41, PHG is in the better half of the industry, outperforming 70.74% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that PHG is somewhat dependend on debt financing.
PHG has a worse Debt to Equity ratio (0.69) than 69.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.67
WACC6.71%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHG should not have too much problems paying its short term obligations.
PHG has a Current ratio of 1.26. This is amonst the worse of the industry: PHG underperforms 81.91% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG's Quick ratio of 0.81 is on the low side compared to the rest of the industry. PHG is outperformed by 85.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.16%, which is quite good.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
The Revenue has decreased by -0.81% in the past year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
3.2 Future
The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.42, PHG is valued correctly.
Based on the Price/Earnings ratio, PHG is valued cheaply inside the industry as 84.57% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.45. PHG is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.47, PHG is valued correctly.
Based on the Price/Forward Earnings ratio, PHG is valued cheaply inside the industry as 84.57% of the companies are valued more expensively.
PHG is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 15.47 |
4.2 Price Multiples
86.17% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than the industry average as 73.40% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 52.53 | ||
| EV/EBITDA | 12.13 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)69.12
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
PHG has a Yearly Dividend Yield of 3.93%. Purely for dividend investing, there may be better candidates out there.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.69. PHG pays more dividend than 98.94% of the companies in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHG pays out 0.62% of its income as dividend. This is a sustainable payout ratio.
DP0.62%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
27.26
+0.55 (+2.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner Change-2.79%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.25B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target31.77 (16.54%)
Short Float %0.26%
Short Ratio2.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.17%
PT rev (3m)1.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.42 | ||
| Fwd PE | 15.47 | ||
| P/S | 1.28 | ||
| P/FCF | 52.53 | ||
| P/OCF | 20.74 | ||
| P/B | 2.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.13 |
EPS(TTM)1.66
EY6.09%
EPS(NY)1.76
Fwd EY6.46%
FCF(TTM)0.52
FCFY1.9%
OCF(TTM)1.31
OCFY4.82%
SpS21.35
BVpS12.41
TBVpS-2.03
PEG (NY)69.12
PEG (5Y)N/A
Graham Number21.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.49% | ||
| ROICexc | 4.97% | ||
| ROICexgc | 16.33% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.9 |
F-Score8
WACC6.71%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NVR- NY / PHG FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PHG.
What is the valuation status for PHG stock?
ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?
KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.
What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 16.42 and the Price/Book (PB) ratio is 2.2.
What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 0.24% in the next year.